Desert Gold Ventures Inc. (OTCBB: DAUGF) (TSE: DAU.V) is an African exploration company that holds assets of significant potential in Rwanda and Mali. DGV's primary objective is to develop proven resources and convert those resources into a socially and environmentally friendly mining operations. The company currently has four highly prospective advanced exploration properties that are all located near producing world-class mines. Desert Gold is currently performing a mining feasibility study at the Byumba gold deposit in Rwanda and has two targeted exploration projects at world-class gold sites in western Mali.
2015 gold production revenues in western Mali exceeded $1.2 Billion USD. Desert Gold is currently in negotiations with two large neighboring mining companies for the co-development of its Farabantourou site. Farabantourou can develop into a world class gold deposit and represents an excellent take-over target for neighboring major producers such as Anglo Ashanti and Randgold. This exit strategy provides investor with excellent short-term upside potential.
Hot Performing Stocks For 2019: First Business Financial Services Inc.(FBIZ)
Advisors' Opinion:- [By Stephan Byrd]
International Bancshares (NASDAQ: IBOC) and First Business Financial Services (NASDAQ:FBIZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.
- [By Shane Hupp]
Get a free copy of the Zacks research report on First Business Financial Services (FBIZ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Performing Stocks For 2019: Frontline Ltd.(FRO)
Advisors' Opinion:- [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks. Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday. Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days. Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension. China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86. J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings. Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory. Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48. Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results. The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash. Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
- [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks. Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday. Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094 vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories. Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days. Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program. J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings. Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday. TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday. Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results. CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210. The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash. Keysight Technologies, Inc. (NYSE: KEY
- [By Logan Wallace]
Pyxis Tankers (NASDAQ: PXS) and Frontline (NYSE:FRO) are both small-cap transportation companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.
- [By Asit Sharma]
Last year, net income dropped from $146.4 million to $101.2 million, creating the sharp trend line seen above. The 2017 earnings dip can be traced to numerous factors, including higher interest expense, a reduction in tanker income, fewer ships in the fleet on charter to former parent Frontline Shipping (NYSE:FRO), and the bankruptcy filing of Seadrill Ltd. (NYSE:SDRL). Seadrill's reorganization has impacted Ship Finance's offshore revenue, as it has three out of four offshore drilling rigs on charter to affiliates of Seadrill.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Frontline (FRO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial. Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday. vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories. Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma. Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading. Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook. Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter. NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat. J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings. TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday. Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates. Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings. TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
Hot Performing Stocks For 2019: Pluristem Therapeutics Inc.(PSTI)
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.
- [By Max Byerly]
Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.
Hot Performing Stocks For 2019: GTT Communications, Inc.(GTT)
Advisors' Opinion:- [By Shane Hupp]
Frontier Communications (NASDAQ: FTR) and GTT Communications (NYSE:GTT) are both utilities companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership.
- [By Lisa Levin]
Analysts at KeyBanc upgraded GTT Communications, Inc. (NYSE: GTT) from Sector Weight to Overweight.
GTT Communications shares fell 0.64 percent to $46.35 in pre-market trading.
- [By Logan Wallace]
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
Get GTT Communications alerts: GTT to Present at Spring 2018 Investor Conferences (finance.yahoo.com) Unified Communications Week in Review: Firstcom, 8×8, RingCentral (unified-communications.tmcnet.com) RingCentral, SD-WAN vendors team up to deliver UCaaS (searchunifiedcommunications.techtarget.com) GTT Communications (GTT) CEO Richard Calder Sells 6,000 Shares (americanbankingnews.com) GTT Communications (GTT) EVP Chris Mckee Sells 7,000 Shares (americanbankingnews.com)GTT has been the topic of several recent research reports. Oppenheimer increased their price objective on GTT Communications from $52.00 to $68.00 in a research report on Tuesday, February 27th. William Blair reiterated a “buy” rating on shares of GTT Communications in a research report on Wednesday, March 28th. Craig Hallum reiterated a “buy” rating and set a $60.00 price objective (up from $50.00) on shares of GTT Communications in a research report on Monday, February 26th. SunTrust Banks increased their price objective on GTT Communications to $60.00 and gave the company a “buy” rating in a research report on Friday, March 2nd. Finally, Jefferies Group increased their price objective on GTT Communications to $62.00 and gave the company a “buy” rating in a research report on Friday, March 2nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $57.22.
Hot Performing Stocks For 2019: Pioneer Floating Rate Trust(PHD)
Advisors' Opinion:- [By Ethan Ryder]
News headlines about Pioneer Floating Rate Trust (NYSE:PHD) have trended somewhat positive on Thursday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pioneer Floating Rate Trust earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media headlines about the investment management company an impact score of 46.8710327510951 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Hot Performing Stocks For 2019: Arcadia Biosciences, Inc.(RKDA)
Advisors' Opinion:- [By Chris Lange]
Arcadia Biosciences, Inc. (NASDAQ: RKDA) watched its shares absolutely explode on Wednesday after the firm announced that it reached a couple key milestones. Specifically, the firm said that it achieved two technology milestones in its High Fiber Resistant Starch (RS) Wheat program.
- [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss. Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results. Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88. Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results. SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results. Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat. Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results. LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results. ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results. Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. MYnd
- [By Max Byerly]
Arcadia Biosciences (NASDAQ: RKDA) and CVR Partners (NYSE:UAN) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.
No comments:
Post a Comment